Here are the top stories for Healio.com/Ophthalmology in the past week:
Eyenovia ’ s piezo-print latanoprost microdose shows positive results
The EYN PG21 study evaluated 60 eyes of 30 healthy volunteers who received one microdose of piezo-print latanoprost each day for 2 consecutive days. Read more.
FDA approves Sun Pharma’s dry eye treatment
Cequa (cyclosporine ophthalmic solution 0.09%), the highest FDA-approved concentration of cyclosporine A and the first to incorporate nanomicellar technology, is indicated to increase tear production. Read more.